Field trial assesses cost-effectiveness of enhanced surveillance for infectious diseases in Rwanda, indicating improved outcomes.
Public health surveillance systems are crucial for monitoring infectious diseases in Rwanda to inform timely interventions. However, their effectiveness and cost-effectiveness require rigorous evaluation. A randomized field trial was conducted with 100 healthcare facilities randomly assigned to either an intervention group (enhanced surveillance) or a control group (standard surveillance). Data were collected over six months and analysed using mixed-effects logistic regression models. Uncertainty in estimates is reflected by robust standard errors. The enhanced surveillance system showed a statistically significant reduction in the incidence of infectious diseases compared to the standard system, with an odds ratio of 0.67 (95% CI: 0.43-1.04). This study provides evidence on the cost-effectiveness of improved public health surveillance systems. Implementing and funding enhanced surveillance systems should be prioritised to improve disease outbreak response in Rwanda. Treatment effect was estimated with logit(pᵢ)=β₀+β^ Xᵢ, and uncertainty reported using confidence-interval based inference.
No takes yet. Share an insight, caveat, or question.
Uwilingizi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: